Evidence map›Paper›PMID 37969386›Full record

ArticleTranslational cancer research2023

Validation of prognostic signature and exploring the immune-related mechanisms for

Daoxun Chen, Zhenjie Yin, Yongmei Chen, Yuanyuan Bai, Bingyong You, Yingming Sun, Yongyang Wu

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daoxun ChenDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, China.
Zhenjie YinDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, China.
Yongmei ChenDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, China.
Yuanyuan BaiDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, China.
Bingyong YouDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, China.
Yingming SunDepartment of Medical and Radiation Oncology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, China.
Yongyang WuDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, China.
Fujian Medical University · CNSanming University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Previous studies have verified that Methods: We first obtained dates from the online public databases. Then R language or online public database was used for bioinformatics analyses to evaluate the effect of Results: The present study yielded significant findings regarding the expression of Conclusions: Our exploratory study suggested that

Indexed as

clear cell renal cell carcinoma (ccRCC)immuneNR3C2prognosisT cells

Identifiers

PMID37969386
PMCPMC10643972
OpenAlexW4387952884

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.